相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide
Alessandra Larocca et al.
BLOOD (2012)
Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer
A. Maraveyas et al.
EUROPEAN JOURNAL OF CANCER (2012)
Epidemiology, risk and outcomes of venous thromboembolism in cancer
A. Falanga et al.
HAMOSTASEOLOGIE (2012)
Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera
H. Reikvam et al.
LEUKEMIA (2012)
Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer
Giancarlo Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
New and old anticoagulants in cancer
Melina Verso et al.
THROMBOSIS RESEARCH (2012)
Low-molecular-weight heparin and survival in lung cancer
Simon Noble
THROMBOSIS RESEARCH (2012)
Mechanisms coupling thrombomodulin to tumor dissemination
Netanel A. Horowitz et al.
THROMBOSIS RESEARCH (2012)
The protein C pathway in cancer metastasis
C. Arnold Spek et al.
THROMBOSIS RESEARCH (2012)
Genetic pathways linking hemostasis and cancer
Delphine Garnier et al.
THROMBOSIS RESEARCH (2012)
Anticancer treatment and thrombosis
Anna Falanga et al.
THROMBOSIS RESEARCH (2012)
Tissue factor isoforms in cancer and coagulation: May the best isoform win
Begum Kocaturk et al.
THROMBOSIS RESEARCH (2012)
Prevention of venous thromboembolism in patients with cancer: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)
Sergio Siragusa et al.
THROMBOSIS RESEARCH (2012)
Microparticles in tumor progression
Anna Falanga et al.
THROMBOSIS RESEARCH (2012)
Acquired hemophilia in malignancy
Brandi N. Reeves et al.
THROMBOSIS RESEARCH (2012)
Platelet CLEC-2 and podoplanin in cancer metastasis
Kate L. Lowe et al.
THROMBOSIS RESEARCH (2012)
Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines
M. Mandala et al.
ANNALS OF ONCOLOGY (2011)
How I treat the acquired von Willebrand syndrome
Andreas Tiede et al.
BLOOD (2011)
Thrombotic Microangiopathy with Targeted Cancer Agents
John A. Blake-Haskins et al.
CLINICAL CANCER RESEARCH (2011)
Randomized Trial of the Effect of the Low Molecular Weight Heparin Nadroparin on Survival in Patients With Cancer
Frederiek F. van Doormaal et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial
Antonio Palumbo et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Venous Thromboembolic Disease
Michael B. Streiff et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2011)
Procoagulant myeloblast-derived microparticles in AML patients: changes in numbers and thrombin generation potential during chemotherapy
M. C. van Aalderen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Rates of venous thromboembolism in multiple myeloma patients undergoing immunomodulatory therapy with thalidomide or lenalidomide: a systematic review and meta-analysis
M. Carrier et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Is extensive screening for cancer in idiopathic venous thromboembolism warranted?
F. F. van Doormaal et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
The expression of annexin II and its role in the fibrinolytic activity in acute promyelocytic leukemia
Yanhui Liu et al.
LEUKEMIA RESEARCH (2011)
Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma
Johannes J. A. Auwerda et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Arterial thrombosis in ambulatory cancer patients treated with chemotherapy
Marcello Di Nisio et al.
THROMBOSIS RESEARCH (2011)
Peripheral arterial ischemic events in cancer patients
Saurabh Sanon et al.
VASCULAR MEDICINE (2011)
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
Anna Falanga et al.
Mediterranean Journal of Hematology and Infectious Diseases (2011)
Comparative assessment of low-molecular-weight heparins in cancer from the perspective of patient outcomes and survival
Anna Falanga et al.
PATIENT-RELATED OUTCOME MEASURES (2011)
Venous thromboembolism in cancer patients: ESMO Clinical Practice Guidelines for the management
M. Mandala et al.
ANNALS OF ONCOLOGY (2010)
Hepatic Veno-Occlusive Disease following Stem Cell Transplantation: Incidence, Clinical Course, and Outcome
Jason A. Coppell et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Prediction of venous thromboembolism in cancer patients
Cihan Ay et al.
BLOOD (2010)
2008 french national guidelines for the treatment of venous thromboembolism in patients with cancer: Report from the working group
Dominique Farge et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2010)
Treatment of thromboembolism in cancer patients
Marina Panova-Noeva et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
The National Comprehensive Cancer Center Network (NCCN) guidelines on the management of venous thromboembolism in cancer patients
Michael B. Streiff
THROMBOSIS RESEARCH (2010)
Prevention and treatment of venous thromboembolism among patients with cancer: The American Society of Clinical Oncology Guidelines
Gary H. Lyman et al.
THROMBOSIS RESEARCH (2010)
Evidence-Based Mini-Review: Should All Patients with Idiopathic Venous Thromboembolic Events Be Screened Extensively for Occult Malignancy?
Rachel Rosovsky et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2010)
Epidemiology of cancer-related venous thromboembolism
Ted Wun et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2009)
Procoagulant mechanisms in tumour cells
Anna Falanga et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2009)
Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
Miguel A. Sanz et al.
BLOOD (2009)
FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer
Gareth O. Griffiths et al.
BMC CANCER (2009)
Tumor-Derived Tissue Factor-Bearing Microparticles Are Associated With Venous Thromboembolic Events in Malignancy
Jeffrey I. Zwicker et al.
CLINICAL CANCER RESEARCH (2009)
Increased Tissue Factor Expression Is Associated with Reduced Survival in Non-Small Cell Lung Cancer and with Mutations of TP53 and PTEN
Sandra Regina et al.
CLINICAL CHEMISTRY (2009)
Gemcitabine with or without prophylactic weight-adjusted dalteparin in patients with advanced or metastatic pancreatic cancer (APC): a multicentre, randomised phase IIB trial (the UK FRAGEM study)
A. Maraveyas et al.
EJC SUPPLEMENTS (2009)
Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia
Marijke C. Trappenburg et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Impact of Venous Thromboembolism and Anticoagulation on Cancer and Cancer Survival
Nicole M. Kuderer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Venous Thromboembolism in the Hematologic Malignancies
Anna Falanga et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Venous Thromboembolism Prophylaxis and Treatment in Cancer: A Consensus Statement of Major Guidelines Panels and Call to Action
Alok A. Khorana et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Assessing Risk of Venous Thromboembolism in the Patient With Cancer
Alok A. Khorana et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients
M. Carrier et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study
Giancarlo Agnelli et al.
LANCET ONCOLOGY (2009)
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism.
Sam Schulman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cancer Awareness in Atypical Thrombotic Microangiopathies
Lucie Oberic et al.
ONCOLOGIST (2009)
Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin
Javier de la Serna et al.
BLOOD (2008)
Development and validation of a predictive model for chemotherapy-associated thrombosis
Alok A. Khorana et al.
BLOOD (2008)
Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy)
Hanno Riess et al.
BMC CANCER (2008)
Antithrombotic therapy for venous thromboembolic disease
Clive Kearon et al.
CHEST (2008)
Thrombosis in myeloproliferative disorders: pathogenetic facts and speculation
R. Landolfi et al.
LEUKEMIA (2008)
Ovarian cancer cells modulate human blood neutrophils response to activation in vitro
M. Klink et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2008)
Chemotherapy-induced thrombosis: A role for microparticles and issue factor?
Daniel Lechner et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2008)
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
A. Palumbo et al.
LEUKEMIA (2008)
Procoagulant factors in patients with cancer
Soledad Molnar et al.
HEMATOLOGY (2007)
American society of clinical oncology guideline: Recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer
Gary H. Lyman et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients
Alok A. Khorana et al.
CANCER (2007)
Tissue factor and PAR signaling in tumor progression
Wolfram Ruf
THROMBOSIS RESEARCH (2007)
Epidemiology of venous thromboembolism in 9489 patients with malignant glioma
Thomas J. Semrad et al.
JOURNAL OF NEUROSURGERY (2007)
Role of protease activated receptor 1 and 2 signaling in hypoxia-induced angiogenesis
Hannele Uusitalo-Jarvinen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer
Russell D. Hull et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Secondary prevention of venous thromboembolic events in patients with active cancer: Enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period
Steven R. Deitcher et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2006)
On the molecular mechanisms for the highly procoagulant pattern of C6 glioma cells
R. S. Fernandes et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Thromboembolism in hospitalized neutropenic cancer patients
AA Khorana et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Venous thromboembolism and cancer: Guidelines of the Italian Association of Medical Oncology (AIOM)
M. Mandala et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2006)
Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer
S Couban et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study
A Cortelezzi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells
JS Palumbo et al.
BLOOD (2005)
Characterization of the cell-surface procoagulant activity of T-lymphoblastoid cell lines
W Pickering et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Efficacy and safety of low-dose aspirin in polycythemia vera
R Landolfi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial
A Piccioli et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Defibrotide reduces procoagulant activity and increases fibrinolytic properties of endothelial cells
A Falanga et al.
LEUKEMIA (2003)
Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer
AYY Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Venous thromboembolism and cancer: Risks and outcomes
AYY Lee et al.
CIRCULATION (2003)
Time- and pH-dependent release of PDGF and TGF-β from platelets in vitro
YW Liu et al.
PLATELETS (2003)
Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor
HK Kim et al.
EUROPEAN JOURNAL OF CANCER (2003)
All-trans-retinoic acid and bleeding/thrombosis
A Falanga et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2003)
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
P Prandoni et al.
BLOOD (2002)
Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer - A randomized controlled study
G Meyer et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer.
D Bergqvist et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Risk factors for deep vein thrombosis and pulmonary embolism -: A population-based case-control study
JA Heit et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: A retrospective analysis
BA Hutten et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
